Company intelligence / Profile preview
i-ChinaPharma-Intelligence
Haikou, Hainan Province, Chinachinapharmaholdings.com ↗
- Ownership
- Private
- Employees
- ~224
- Development stage
- Other
01
Overview
China Pharma Holdings develops, manufactures, and markets a broad range of generic pharmaceuticals and some traditional Chinese medicines for high-incidence diseases in China. Their products include injectables, tablets, capsules, granules, and oral solutions targeting infectious diseases, CNS disorders, cardiovascular conditions, digestive diseases and more. The company has over 16 commercialized drugs with ongoing development in new generics.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small moleculeTraditional Chinese medicineBiologic
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on i-ChinaPharma-Intelligence.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on i-ChinaPharma-Intelligence.